Content about Bronchodilators

September 18, 2012
BI launches Combivent Respimat

Boehringer Ingelheim Pharmaceuticals has launched a drug for treating chronic obstructive pulmonary disease, the company said Tuesday.

August 20, 2012
Prasco, Sunovion enter agreement over Xopenex authorized generic

Prasco Labs is distributing an authorized generic version of a respiratory drug under an agreement with the branded drug's manufacturer.

July 24, 2012
FDA approves new COPD drug

The Food and Drug Administration has approved a new drug made by Forest Labs for treating chronic obstructive pulmonary disease, the agency said.

June 21, 2012
COPD spurs drug development

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention.

May 29, 2012
Mylan settles with Sunovion over generic asthma, COPD drug

A unit of generic drug maker Mylan has settled with Sunovion Pharmaceuticals over a drug used to treat chronic obstructive pulmonary disease and asthma.

March 9, 2012
FDA approves Teva inhaler with dose counter

The Food and Drug Administration has approved a version of a drug made by Teva that includes a dose counter, the drug maker said.

February 17, 2012
COPD pipeline grows 
despite patent cliff

One of the main plotlines of the big story called the drug industry over the past several years has been the patent cliff, the steady loss of patent protection on blockbuster primary care drugs and subsequent generic competition that has forced many drug companies to find new revenue streams.

February 14, 2012
Mylan to challenge court decision over generic asthma, COPD drug

Generic drug maker Mylan plans to challenge a court decision that requires it to pay almost $20 million to a drug company whose product it tried to market as a generic.

October 10, 2011
FDA approves Boehringer Ingelheim COPD treatment

The Food and Drug Administration has approved a new product for chronic obstructive pulmonary disease made by Boehringer Ingelheim Pharmaceuticals, the drug maker said.

September 22, 2011
OTC asthma inhalers phased out by year end

Epinephrine inhalers will not be made or sold after Dec. 31, and patients using them should get new prescriptions to replace them, the Food and Drug Administration said Thursday.

April 12, 2010
FDA to begin removing inhalers containing CFC propellants from market

The Food and Drug Administration will start phasing out asthma and chronic obstructive pulmonary disease...

February 1, 2010
Decision Resources: Spiriva to remain clinical gold standard as COPD treatment

A drug from Boehringer Ingelheim and Pfizer will retain Decision Resources’ status as a gold...

January 13, 2010
FDA finds Spiriva does not raise risk of heart attack, stroke

Data from a recent review of a treatment for chronic obstructive pulmonary disease do not...

© 2013 Drug Store News. All Rights Reserved.